Adverum Biotechnologies Inc (NASDAQ:ADVM) Climbs 8.28% In 2025; Is It Attractive Enough At $2.12?
In last trading session, Adverum Biotechnologies Inc (NASDAQ:ADVM) saw 0.39 million shares changing hands with its beta currently measuring 0.68. Company’s recent per share price